mdlinx mdlinx
Latest (44) Full Text Articles (2496) Focus on Stroke Article Summary

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon {beta}-1b in patients with multiple sclerosis
Journal of Neurology, Neurosurgery & Psychiatry, Exclusive Author Commentary  Clinical Article

Soilu–Hanninen M et al. – Vitamin D3 add on treatment to interferon β–1b (IFNB) reduces MRI disease activity in multiple sclerosis (MS).

Methods
  • 1 year, double blind, placebo controlled, randomised study in 66 MS patients.
  • The primary outcomes were T2 burden of disease (BOD) on MRI scans, proportion of patients with serum levels of 25-hydroxyvitamin D (25(OH)D) ≥85 nmol/l or intact parathyroid hormone (PTH) ≤20 ng/l, and number of adverse events.
  • Secondary outcomes were number of MRI enhancing T1 lesions and new T2 lesions, annual relapse rate, changes in the Expanded Disability Status Scale score, timed 25 foot walk test and timed 10 foot tandem walk tests.

Results
  • Median change in BOD was 287 mm3 in the placebo group and 83 mm3 in the vitamin D group (p=0.105).
  • Serum levels of 25(OH)D increased from a mean of 54 (range 19–82) nmol/l to 110 (range 67–163) nmol/l in the vitamin D group. 84% of patients reached a serum 25(OH)D level >85 nmol/l in the vitamin D group and 3% in the placebo group (p<0.0001).
  • Patients in the vitamin D group showed fewer new T2 lesions (p=0.286) and a significantly lower number of T1 enhancing lesions (p=0.004), as well as a tendency to reduced disability accumulation (p=0.071) and to improved timed tandem walk (p=0.076).
  • There were no significant differences in adverse events or in the annual relapse rate.

Our paper is the first randomised double-blind placebo controlled trial with vitamin D3 in MS patients with MRI outcomes. The most important results was the statistically significant reduction on Gd+ lesion in the vitamin D3 treated patients in comparison with the placebo group as well as the trends in MRI BOD, EDSS and timed tandem walk test. Our patients had active MS with an ARR of 0.51 before the trial onset and all of them were using interferon-beta 1b. It is possible that interferon-beta and vitamin D3 have a synergistic effects in MS. This is one explanation for the discrepancy with the negative results from another RCT (Kampman et al, Multiple sclerosis Epub ahead of print Feb 2012.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Neurology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Neurology Articles

Last month's top read Top Articles of 2013

1 Tremor JAMA, March 7, 2014    Review Article    Clinical Article

2 C-reactive protein as a prognostic marker after lacunar stroke Stroke, March 3, 2014    Clinical Article

3 Intakes of potassium, magnesium, and calcium and risk of stroke Stroke, March 25, 2014    Clinical Article

4 Long-term, serial screening for intracranial aneurysms in individuals with a family history of aneurysmal subarachnoid haemorrhage: A cohort study The Lancet Neurology, March 17, 2014    Review Article

5 Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation? Thrombosis and Haemostasis, January 17, 2014    Clinical Article

6 Statins and vascular dementia: A review Journal of Alzheimer’s Disease, March 27, 2014    Review Article

7 Risk and benefit of statins in stroke secondary prevention Current Vascular Pharmacology, March 26, 2014    Review Article

8 Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease Parkinsonism & Related Disorders, March 3, 2014    Clinical Article

9 Primary Sjögren's syndrome and risk of ischemic stroke: A nationwide study Clinical Rheumatology, March 24, 2014    Clinical Article

10 Dabigatran for stroke prevention in nonvalvular atrial fibrillation: Focus in the geriatric population The Consultant Pharmacist, March 5, 2014    Clinical Article

11 Patients with epilepsy are at an increased risk of subsequent stroke: A population-based cohort study Seizure - European Journal of Epilepsy, March 14, 2014    Clinical Article

12 Antivitamin K drugs in stroke prevention Current Vascular Pharmacology, March 28, 2014    Clinical Article

13 Risk of stroke associated with nonsteroidal anti-inflammatory drugs Full Text Vascular Health and Risk Management, January 13, 2014    Free full text    Review Article    Clinical Article

14 Prevention opportunities for oral contraceptive–associated ischemic stroke Stroke, March 6, 2014    Clinical Article

15 Early treatment of hypertension in acute ischemic and intracerebral hemorrhagic stroke: Progress achieved, challenges, and perspectives Journal of the American Society of Hypertension, March 20, 2014    Review Article

16 Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study The Lancet Neurology, March 12, 2014    Clinical Article

17 Continuous antihypertensive therapy throughout the initial 24 hours of intracerebral hemorrhage Stroke, March 5, 2014    Clinical Article

18 A practical approach to neurologic evaluation in the intensive care unit Journal of Critical Care, March 3, 2014    Clinical Article

19 Acupuncture enhances effective connectivity between cerebellum and primary sensorimotor cortex in patients with stable recovery stroke Full Text Evidence-based Complementary and Alternative Medicine , March 14, 2014    Free full text    Clinical Article

20 Acupuncture modulates the functional connectivity of the default mode network in stroke patients Full Text Evidence-based Complementary and Alternative Medicine , March 13, 2014    Free full text    Clinical Article

Indexed Journals in Neurology: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injurymore

Other Topics in Neurology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close